Cleavage of N-H Bond of Ammonia via Metal-Ligand Cooperation Enables Rational Design of a Conceptually New Noyori-Ikariya Catalyst.
Pavel A DubAsuka MatsunamiShigeki KuwataYoshihito KayakiPublished in: Journal of the American Chemical Society (2019)
The asymmetric transfer hydrogenation (ATH) of ketones/imines with Noyori-Ikariya catalyst represents an important reaction in both academia and fine chemical industry. The method allows for the preparation of chiral secondary alcohols/amines with very good to excellent optical purities. Remarkably, the same chiral Noyori-Ikariya complex is also a precatalyst for a wide range of other chemo- and stereoselective reductive and oxidative transformations. Among them are enantioselective sulfonamidation of acrylates (intramolecular aza-Michael reaction) and carboxylation of indoles with CO2. Development of these catalytic reactions has been inspired by the realized cleavage of the N-H bond of sulfonamides and indoles by the 16e- amido derivative of the 18e- precatalyst via metal-ligand cooperation (MLC). This paper summarizes our efforts to investigate N-H bond cleavage of gaseous ammonia in solution via MLC and reports the serendipitous discovery of a new class of chiral tridentate κ3[ N, N', N″] Ru and Ir metallacycles, derivatives of the famous M-FsDPEN catalysts (M = Ru, Ir). The protonation of these metallacycles by strong acids containing weakly coordinating (chiral) anions generates ionic complexes, which were identified as conceptually novel Noyori-Ikariya precatalysts. For example, the ATH of aromatic ketones with some of these complexes proceeds with up to 99% ee.
Keyphrases
- ionic liquid
- room temperature
- capillary electrophoresis
- dna binding
- electron transfer
- transition metal
- highly efficient
- energy transfer
- small molecule
- high resolution
- metal organic framework
- emergency department
- high throughput
- mass spectrometry
- photodynamic therapy
- anaerobic digestion
- transcription factor
- amino acid
- radiation therapy
- squamous cell carcinoma
- locally advanced
- cancer therapy
- reduced graphene oxide
- electronic health record